Promotions & Moves

BioIVT Names Richard Haigh CEO

Haigh brings more than 27 years of experience in the life science research and diagnostics space.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioIVT, LLC, a leading global provider of biospecimens, cell and gene therapy related products, and research models and services for drug development purposes, has promoted Richard Haigh, Ph.D., to Chief Executive Officer, effective August 1. Dr. Haigh joined BioIVT in May 2022 as Chief Operating Officer and brings more than 27 years of experience in the life science research and diagnostics space covering products, consumables, and services, including over 15 years with Thermo Fisher Scientific...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters